Clinical Trial Update: Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antimetabolite induction and high-dose alkylating agent consolidation followed by retroviral MDR1 gene transduction and sequential pacl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED